Searchable abstracts of presentations at key conferences in endocrinology

ea0063p717 | Pituitary and Neuroendocrinology 2 | ECE2019

Glycogenosis and hypofisis pathology, importance of a multidisciplinary management

Cornejo-Pareja Isabel , Maraver-Selfa Silvia , Munoz-Garach Araceli , Gonzalo-Marin Montserrat , Hernandez-Garcia Carmen , Damas-Fuentes Miguel , Mancha-Doblas Isabel , Tinahones Francisco J

Introduction: Glycogenosis is a group of hereditary diseases affecting the glycogen metabolism, due to mutations in enzymes involved in the transformation and synthesis of glucose (liver and muscle glycogenosis). Brain germ tumors are very infrequent. They are located mainly in pineal and sellar region. Central diabetes insipidus is the most frequent manifestation. Their prognosis and response to combined chemo/radiotherapy treatment are favorable.Case r...

ea0063p906 | Diabetes, Obesity and Metabolism 3 | ECE2019

Gestational Diabetes in Early Pregnancy – what does fasting glucose tell us?

Rosinha Patricia , Dantas Rosa , Alves Marcia , Azevedo Teresa , Inacio Isabel , Ferreira Sara Esteves , Pedrosa Carla , Albuquerque Isabel , Garrett Ana Catarina , Guimaraes Joana

Introduction: The association of fasting glucose (FG) in early pregnancy (EP) with adverse outcomes for the mother and her offspring is well known, although the best cut-offs for diagnosis of Gestational Diabetes (GD) are not consensual.Objetive: Evaluate the impact of FG in EP in the management of pregnant women and obstetric and fetal outcomes.Methods: Retrospective cohort of pregnant women with GD diagnosed before 24 weeks of ge...

ea0063p910 | Diabetes, Obesity and Metabolism 3 | ECE2019

Gestational Diabetes: what to say about body mass index and outcomes? The influence of prepregnancy body mass index on obstetric and neonatal outcomes of women with gestational diabetes

Ferreira Sara Esteves , Rosinha Patricia , Inacio Isabel , Alves Marcia , Azevedo Teresa , Dantas Rosa , Pedrosa Carla , Ferreira Marilia , Albuquerque Isabel , Fonseca Catarina , Jesus Andreia , Guimaraes Joana

Introduction: Due to the growing prevalence of obesity, more women are overweight in early pregnancy, leading to adverse neonatal and obstetric outcomes.Objective: To evaluate the influence of maternal prepregnancy body mass index (BMI) on blood glucose levels at diagnosis of gestational diabetes (GD), obstetric and neonatal outcomes.Methods: Retrospective observational study including women with GD and singleton pregnancy, with fo...

ea0049ep100 | Adrenal medulla | ECE2017

Lung adenocarcinoma in a 34-year-old female SDHB asynptomatic mutation carrier – case report

Matos Maria Joao , Costa Claudia , Santos Ana Paula , Teixeira Manuel , Franco Carlos , Bento Joao , Azevedo Isabel , Dias Susana , Sampaio Ines Lucena , Cunha Ana Luisa , Torres Isabel

Introduction: Patients with germline mutations in one of the succinate dehydrogenase (SDH) genes are at substantially increased risk of developing paragangliomas (PGL) and pheochromocytomas (PCC). Mutations in SDHB are the most commonly found gene mutations in PC/PGL and are associated with younger ages at presentation, higher rates of metastases and poorer prognosis. Although familial PGL syndromes were initially thought to predispose only for PCC and PGL, other tumor types s...

ea0049ep614 | Diabetes therapy | ECE2017

New long-acting insulins in type 1 diabetes: implications for real clinical practice

Damas-Fuentes Miguel , Diaz-Perdigones Cristina , Munoz-Garach Araceli , Molina-Vega Maria , Hernandez-Garcia Carmen , Cornejo-Pareja Isabel , Mancha-Doblas Isabel , Tinahones-Madueno Francisco J

The emergence of a new generation of long-acting insulin analogues (insulin degludec -ID- and insulin glargine 300 U/ml -IG300-) has increased treatment options in type 1 diabetes (T1D), demonstrating in clinical trials better metabolic control with lower hypoglycemia rates.Objectives: To assess characteristics of T1D patients who were given ID and IG300 in clinical practice and to evaluate their effect on metabolic control, weight, insulin dose and hypo...

ea0041oc7.1 | Cardiovascular endocrinology | ECE2016

Lipoprotein lipase DNA methylation: cause or consequence of metabolic disorders

Castellano-Castillo Daniel , Moreno-Indias Isabel , Queipo-Ortuno Maria Isabel , Fernandez-Garcia Jose Carlos , Alcaide-Torres Juan , Tinahones Francisco , Cardona-Diaz Fernando

Introduction: DNA methylation is one of the epigenetic mechanisms existing to regulate gene expression. It is believed that methylation of DNA is susceptible of change by environmental and nutritional factors. Thus, epigenetics provides a mechanism which may explain the etiology of some metabolic disorders and obesity.Aim: The aim of this study is to analyze the DNA methylation level of several lipoprotein lipase (LPL)-promoter-CpG island in human viscer...

ea0041gp137 | Obesity | ECE2016

Adipose tissue infiltration in normal-weight subjects and its impact on metabolic function

Moreno-Indias Isabel , Oliva-Olivera Wilfredo , Castellano-Castillo Daniel , Lhamyani Said , Fernandez-Garcia Jose Carlos , Queipo-Ortuno Maria Isabel , Cardona-Diaz Fernando , Tinahones Francisco

Objectives: To study for the first time the differences in monocyte/macrophage infiltration, inflammation and adipogenesis in the subcutaneous and visceral adipose tissues of normal-weight subjects who differed in their degree of metabolic syndrome.Methods: The study included 92 normal-weight subjects who differed in their degree of metabolic syndrome. Anthropometric and biochemical parameters were measured. RNA from subcutaneous and visceral adipose tis...

ea0037ep718 | Pituitary: clinical | ECE2015

Pituitary adenoma of aggressive behaviour

Selfa Silvia Maraver , Perez Ana Gomez , Doblas Isabel Mancha , Pareja Isabel Maria Cornejo , Vega Maria Molina , Perdigones Cristina Diaz , Madueno Francisco Tinahones

Pituitary ACTH-secreting tumour presents with variety of clinical features: normal cortisol secretion and ACTH-immunopositive staining and mild hypercortisolism without typical features of Cushing’s disease. We present a 53-year-old male with history of hypertension. First visit (2005): visual loss, bitemporal hemianopsia in campimetry and in MRI pituitary adenoma (2.5 cm) invading cavernous sinus and suprasellar cister. Hormonal study supported panhypopituitarism. After ...

ea0037ep1169 | Clinical Cases–Pituitary/Adrenal | ECE2015

Oncocytic adrenal cortical adenoma presenting as Cushing's syndrome: an exceptional clinical entity

Vega Maria Molina , Garach Araceli Munoz , Selfa Silvia Maraver , Perez Ana Gomez , Pareja Isabel Cornejo , Perdigones Cristina Diaz , Doblas Isabel Mancha , Madueno Francisco Tinahones

Introduction: Oncocytomas are tumours composed by oncocytes, cells with granular and eosinophilic cytoplasm filled with mitochondria. It is a neoplasm that can arise in several organs (more commonly described in the kidney, salivary gland and thyroid). Oncocytoma arising in the adrenal gland is a rare finding. Most of them are benign and non-functioning and are detected incidentally. However, functional adrenal oncocytomas presenting as Cushing’s syndrome and phaeochromoc...

ea0035p1086 | Thyroid Cancer | ECE2014

Symptomatic hypercalcemia due to primary hyperparathyroidism by parathyroid carcinoma

Cornejo-Pareja Isabel , Gomez-Perez Ana , Maraver-Selfa Silvia , Munoz-Garach Araceli , Molina-Vega Maria , Mancha-Doblas Isabel , Tinahones-Madueno Francisco

Parathyroid carcinoma is a rare cause of primary hyperparathyroidism. Clinical suspicion is determined by the severity of hyperparathyroidism associated or not with palpable cervical tumor and local invasion when surgery.Case report: A 45-year-old woman without any previous history of kidney stones or fractures. Admitted to hospital because of high hypercalcemia (calcium 15.1 mg/dl), fatigue and generalized arthralgia. Physical examination revealed right...